Table 5.

Live births for treated patients by carrier status and allelic dose.

All treated patients with complete genetic testing data
		Live births		No live births		Total (N = 96)a	p-Value
(N = 36)	%	(N = 60)	%
C4M2 carrier status	Female carrier/homozygote	9	25.0%	26	43.3%	35
Male carrier/homozygote	21	58.3%	23	38.3%	44	0.0452 (Male vs. Female only)
Both carrier/homozygote	6	16.7%	11	18.3%	17
Number of alleles	1	29	39.7%	44	60.3%	73	0.4222
2 to 3	7	30.4%	16	69.6%	23

1 includes: (WT/WT)/(WT/M2); (WT/WT)/(M1/M2); (WT/M2)/(WT/M1); (WT/M2)/(M1/M1).

2 includes: (WT/M2)/(WT/M2); (WT/M2)/(M1/M2); (WT/WT)/(M2/M2); (WT/M1)/(M2/M2).

3 includes: (WT/M2)/(M2/M2).

^aSeven couples with incomplete genetic testing data have been excluded (five untested males and two untested females).